Luke Nordquist, MD, FACP, CEO
drluke@xcancer.comTony Romero, MS, CCRC, Director of Research
tromero@gucancer.comDescription:
This is a single arm study to evaluate the safety and biodistribution of 89Zr-labeled NY008 PET Imaging in patients with multiple myeloma
Phase:
Early Phase 1
Government Study Link:
NCT05655676 - Click here to see study onClinicalTrials.gov
Help us improve your experience